Skip to main content
. 2022 Oct 8;17:100453. doi: 10.1016/j.mtbio.2022.100453

Table 3.

Applied HA hydrogels scaffolding technologies in Cancer disease.

Chemistry Models Scaffold Application Biological Assessment Properties Assessment Biological Assay Ref.
HA-methacrylate 2D/3D Brain matrix-mimetic platform 373-MG human GBM cells
U87-MG human GBM cells
Rat C6 glioma cells
Swelling Elastic modulus
Gel microstructure (SEM)
Cell viability [101]
HA-methacrylate 2D/3D Inhibition of cell migration 373-MG human GBM cells
U87-MG human GBM cells
Time-lapse Microscopy
Analysis of Cell Migration
Cell Morphological Analyses
[105]
HA-acrylate
HA-reactive thiols
2D/3D ECM-mimetic platform PCa human prostate adenocarcinoma cells Swelling
Rheological behavior
Degradation
Cell Viability
Cell proliferation
Cell Morphological Analyses
Cell-cell adhesion
Expression of angiogenic factors
[108]
HA-RGD 3D ECM-mimetic platform
Alkylating chemotherapies drugs treatment
GBM cell lines derived from patients Cell proliferation
Expression of BCL-2 family factors
Cell Morphological Analyses
[110]
HA-methacrylate-RGD 2D 3D Matrix stiffness
Drug resistance
MDA-MB-231 breast cancer cells Swelling
Elastic Modulus
Mesh Size
Cell proliferation
Cell Morphological Analyses
[113,114]
HA-methacrylate 2D/3D ECM-mimetic platform Patient-derived D456 ​cells
U87-MG human GBM cells
Cell proliferation
Apoptosis Assay
Cell Morphological Analyses
Stemness markers expression
[116]